Back to News
Market Impact: 0.2
ViroMissile Appoints Diane Simeone, M.D., and Matt Mulvey, Ph.D. as Advisors
Source: GlobeNewswire
Healthcare & BiotechManagement & Governance
The company announced appointments intended to add scientific, clinical, and business expertise as three intravenously dosed oncolytic viral programs advance in Phase 1 trials. The article provides no names, trial results, or other quantitative details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Trump created a committee to dig into the Fed's Lisa Cook. What is it and what comes next?
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss
- ‘Indentured servants’: US green card move will hit thousands of IT workers
- Teva wins FDA approval for monthly schizophrenia injection Weltruza
- BofA downgrades Alignment Healthcare stock rating on star rating drop
- Trump launches probe into Federal Reserve Governor Lisa Cook